Daily Derm Times: July 9, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Journal Digest: July 9, 2025

This review of the latest dermatologic studies includes insights into immunomodulatory effects of photodynamic therapy for skin cancer, in vivo and ex vivo sonographic evaluation of tumor margins, and more.

Navigating Changes in Dermatology and Clinical Research Efforts

Explore the latest advancements in dermatology in our July issue, from innovative treatments to AI in skin care, shaping the future of skin health and research.

Optimal Targets Linked to Better AD Outcomes

Achieving optimal treatment targets and minimal disease activity significantly enhances health-related quality of life and satisfaction in patients with atopic dermatitis.

Tralokinumab Shows Hand Relief in ADHAND Trial

LEO Pharma reveals promising interim results for tralokinumab in treating moderate to severe atopic dermatitis on hands, enhancing patient quality of life.

Q&A: Bridging the Gap in Dermatologic Care with a Provider-First Digital Solution

Miiskin is transforming dermatologic care through telehealth, enhancing access, efficiency, and patient relationships, according to Ryan Trowbridge, MD, MS, MA, FAAD.

POLL: Do You Routinely Use Patch Testing When Evaluating Chronic Hand Eczema?

Click here to answer our poll.

Delgocitinib Cream Shows Minimal Systemic Absorption in CHE

Delgocitinib cream offers a safe, effective treatment for chronic hand eczema with minimal systemic absorption, ensuring no significant immunosuppressive effects.